Your Messages Inbox
Your Article Summary
See Latest ArticlesNew Diabetes Device May Be Next Step in Quest for Artificial Pancreas
Medtronic, 09/03/09
At this year's annual meeting of the International Society for Pediatric and Adolescent Diabetes in Ljubljana, Slovenia, Medtronic, Inc. announced the global launch of a novel technology designed to provide additional protection against the risks associated with hypoglycemia. This new device, now available in more than 50 countries outside of the United States, can automatically suspend insulin delivery when the device senses that glucose levels have fallen to or below a user–selected threshold. This feature is intended to reduce the severity of low blood sugar in situations where patients ignore or are unable to treat hypoglycemia.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Article Search
Sponsor